PMC:7283670 / 79073-79250 JSONTXT

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T316","span":{"begin":88,"end":90},"obj":"Chemical"}],"attributes":[{"id":"A316","pred":"chebi_id","subj":"T316","obj":"http://purl.obolibrary.org/obo/CHEBI_73579"}],"text":"Experimental: pathogen‐specific DC and CTLs patients will receive approximately 5 × 106 LV‐DC vaccine and 1 × 108 CTLs via subcutaneous injections and iv infusions, respectively"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1935","span":{"begin":44,"end":52},"obj":"Species"}],"attributes":[{"id":"A1935","pred":"tao:has_database_id","subj":"1935","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Experimental: pathogen‐specific DC and CTLs patients will receive approximately 5 × 106 LV‐DC vaccine and 1 × 108 CTLs via subcutaneous injections and iv infusions, respectively"}